{"pageContent": "Purpose: Pathological and oncologic outcomes of delayed radical prostatectomy following prostate cancer active surveillance are not well established. We determined the pathological and oncologic outcomes of favorable risk, Grade Group 1, prostate cancer managed with active surveillance and progressing to radical prostatectomy for clinically significant prostate cancer (Grade Group 2 or greater).", "metaData": {"source": "Erectile function outcome reporting after clinically localized prostate cancer treatment\nhttps://pubmed.ncbi.nlm.nih.gov/17570435/"}}